{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T02:03:47Z","timestamp":1774490627418,"version":"3.50.1"},"reference-count":80,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,3,1]],"date-time":"2019-03-01T00:00:00Z","timestamp":1551398400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,3,1]],"date-time":"2019-03-01T00:00:00Z","timestamp":1551398400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,6,8]],"date-time":"2022-06-08T00:00:00Z","timestamp":1654646400000},"content-version":"vor","delay-in-days":1195,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["17929899"],"award-info":[{"award-number":["17929899"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["17930095"],"award-info":[{"award-number":["17930095"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["17935423"],"award-info":[{"award-number":["17935423"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","exphem.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Experimental Hematology"],"published-print":{"date-parts":[[2019,3]]},"DOI":"10.1016\/j.exphem.2019.01.005","type":"journal-article","created":{"date-parts":[[2019,1,18]],"date-time":"2019-01-18T22:22:19Z","timestamp":1547850139000},"page":"43-50","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"C","title":["Application of induced pluripotent stem cells to primary immunodeficiency diseases"],"prefix":"10.1016","volume":"71","author":[{"given":"Peter","family":"Karagiannis","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shinya","family":"Yamanaka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8813-3614","authenticated-orcid":false,"given":"Megumu K.","family":"Saito","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.exphem.2019.01.005_bib0001","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1016\/S0140-6736(72)92345-8","article-title":"Adenosine-deaminase deficiency in two patients with severely impaired cellular immunity","volume":"2","author":"Giblett","year":"1972","journal-title":"Lancet"},{"key":"10.1016\/j.exphem.2019.01.005_bib0002","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1002\/ajmg.a.38480","article-title":"From clinical observations and molecular dissection to novel therapeutic strategies for primary immunodeficiency disorders","volume":"176","author":"Ochs","year":"2018","journal-title":"Am J Med Genet A"},{"key":"10.1016\/j.exphem.2019.01.005_bib0003","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1016\/S0140-6736(68)92673-1","article-title":"Immunological reconstitution of sex-linked lymphopenic immunological deficiency","volume":"2","author":"Gatti","year":"1968","journal-title":"Lancet"},{"key":"10.1016\/j.exphem.2019.01.005_bib0004","doi-asserted-by":"crossref","first-page":"937","DOI":"10.3389\/fimmu.2017.00937","article-title":"Primary immunodeficiency diseases: current and emerging therapeutics","volume":"8","author":"Marciano","year":"2017","journal-title":"Front Immunol"},{"key":"10.1016\/j.exphem.2019.01.005_bib0005","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1016\/j.ymthe.2017.03.018","article-title":"Evolving gene therapy in primary immunodeficiency","volume":"25","author":"Thrasher","year":"2017","journal-title":"Mol Ther"},{"key":"10.1016\/j.exphem.2019.01.005_bib0006","doi-asserted-by":"crossref","first-page":"142","DOI":"10.3389\/fimmu.2015.00142","article-title":"Novel primary immunodeficiency candidate genes predicted by the human gene connectome","volume":"6","author":"Itan","year":"2015","journal-title":"Front Immunol"},{"key":"10.1016\/j.exphem.2019.01.005_bib0007","doi-asserted-by":"crossref","first-page":"2137","DOI":"10.1084\/jem.20140520","article-title":"Guidelines for genetic studies in single patients: lessons from primary immunodeficiencies","volume":"211","author":"Casanova","year":"2014","journal-title":"J Exp Med"},{"issue":"Suppl 1","key":"10.1016\/j.exphem.2019.01.005_bib0008","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1007\/s10875-016-0260-y","article-title":"Next generation sequencing data analysis in primary immunodeficiency disorders: future directions","volume":"36","author":"Fang","year":"2016","journal-title":"J Clin Immunol"},{"issue":"2","key":"10.1016\/j.exphem.2019.01.005_bib0009","first-page":"15","article-title":"Rescue of recurrent deep intronic mutation underlying cell type-dependent quantitative NEMO deficiency","volume":"129","author":"Boisson","year":"2019","journal-title":"J Clin Invest"},{"key":"10.1016\/j.exphem.2019.01.005_bib0010","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1007\/s10875-014-0076-6","article-title":"Inborn errors of metabolism underlying primary immunodeficiencies","volume":"34","author":"Parvaneh","year":"2014","journal-title":"J Clin Immunol"},{"key":"10.1016\/j.exphem.2019.01.005_bib0011","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.it.2015.12.006","article-title":"Primary immunodeficiencies and inflammatory disease: a growing genetic intersection","volume":"37","author":"Fodil","year":"2016","journal-title":"Trends Immunol"},{"key":"10.1016\/j.exphem.2019.01.005_bib0012","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.siny.2015.12.005","article-title":"Primary immunodeficiency in the neonate: early diagnosis and management","volume":"21","author":"Walkovich","year":"2016","journal-title":"Semin Fetal Neonatal Med"},{"key":"10.1016\/j.exphem.2019.01.005_bib0013","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1038\/gim.2017.57","article-title":"Utilization of genomic sequencing for population screening of immunodeficiencies in the newborn","volume":"19","author":"Pavey","year":"2017","journal-title":"Genet Med"},{"key":"10.1016\/j.exphem.2019.01.005_bib0014","doi-asserted-by":"crossref","first-page":"847","DOI":"10.3389\/fimmu.2017.00847","article-title":"Uses of next-generation sequencing technologies for the diagnosis of primary immunodeficiencies","volume":"8","author":"Seleman","year":"2017","journal-title":"Front Immunol"},{"key":"10.1016\/j.exphem.2019.01.005_bib0015","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/j.stem.2015.02.005","article-title":"Lymphoid regeneration from gene-corrected SCID-X1 subject-derived iPSCs","volume":"16","author":"Menon","year":"2015","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.exphem.2019.01.005_bib0016","doi-asserted-by":"crossref","first-page":"E8775","DOI":"10.1073\/pnas.1809853115","article-title":"Human iPSC-derived trigeminal neurons lack constitutive TLR3-dependent immunity that protects cortical neurons from HSV-1 infection","volume":"115","author":"Zimmer","year":"2018","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.exphem.2019.01.005_bib0017","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1038\/ncb3419","article-title":"Progress towards generation of human haematopoietic stem cells","volume":"18","author":"Wahlster","year":"2016","journal-title":"Nat Cell Biol"},{"key":"10.1016\/j.exphem.2019.01.005_bib0018","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1152\/physrev.00039.2017","article-title":"Induced pluripotent stem cells and their use in human models of disease and development","volume":"99","author":"Karagiannis","year":"2019","journal-title":"Physiol Rev"},{"key":"10.1016\/j.exphem.2019.01.005_bib0019","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1016\/j.cell.2007.11.019","article-title":"Induction of pluripotent stem cells from adult human fibroblasts by defined factors","volume":"131","author":"Takahashi","year":"2007","journal-title":"Cell"},{"key":"10.1016\/j.exphem.2019.01.005_bib0020","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/j.cell.2006.07.024","article-title":"Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors","volume":"126","author":"Takahashi","year":"2006","journal-title":"Cell"},{"key":"10.1016\/j.exphem.2019.01.005_bib0021","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/j.stem.2009.05.015","article-title":"Naive and primed pluripotent states","volume":"4","author":"Nichols","year":"2009","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.exphem.2019.01.005_bib0022","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1016\/j.cell.2014.08.029","article-title":"Resetting transcription factor control circuitry toward ground-state pluripotency in human","volume":"158","author":"Takashima","year":"2014","journal-title":"Cell"},{"key":"10.1016\/j.exphem.2019.01.005_bib0023","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/j.stem.2014.07.002","article-title":"Systematic identification of culture conditions for induction and maintenance of naive human pluripotency","volume":"15","author":"Theunissen","year":"2014","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.exphem.2019.01.005_bib0024","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1126\/science.1158799","article-title":"Induced pluripotent stem cells generated from patients with ALS can be differentiated into motor neurons","volume":"321","author":"Dimos","year":"2008","journal-title":"Science"},{"key":"10.1016\/j.exphem.2019.01.005_bib0025","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1038\/nature08320","article-title":"Modelling pathogenesis and treatment of familial dysautonomia using patient-specific iPSCs","volume":"461","author":"Lee","year":"2009","journal-title":"Nature"},{"key":"10.1016\/j.exphem.2019.01.005_bib0026","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1189\/jlb.5A1016-445R","article-title":"Elastase inhibitors as potential therapies for ELANE-associated neutropenia","volume":"102","author":"Makaryan","year":"2017","journal-title":"J Leukoc Biol"},{"key":"10.1016\/j.exphem.2019.01.005_bib0027","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.ebiom.2017.03.042","article-title":"New models for therapeutic innovation from japan","volume":"18","author":"Karagiannis","year":"2017","journal-title":"EBioMedicine"},{"key":"10.1016\/j.exphem.2019.01.005_bib0028","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.jbior.2018.10.001","article-title":"Application of induced pluripotent stem cell technology for the investigation of hematological disorders","volume":"71","author":"Dolatshad","year":"2019","journal-title":"Adv Biol Regul"},{"key":"10.1016\/j.exphem.2019.01.005_bib0029","doi-asserted-by":"crossref","first-page":"333","DOI":"10.5966\/sctm.2013-0172","article-title":"Pluripotent cell models of fanconi anemia identify the early pathological defect in human hemoangiogenic progenitors","volume":"4","author":"Suzuki","year":"2015","journal-title":"Stem Cells Transl Med"},{"key":"10.1016\/j.exphem.2019.01.005_bib0030","doi-asserted-by":"crossref","first-page":"eaah5645","DOI":"10.1126\/scitranslmed.aah5645","article-title":"Drug discovery for Diamond\u2013Blackfan anemia using reprogrammed hematopoietic progenitors","volume":"9","author":"Doulatov","year":"2017","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.exphem.2019.01.005_bib0031","doi-asserted-by":"crossref","first-page":"19","DOI":"10.3324\/haematol.2013.083873","article-title":"Genetic correction of HAX1 in induced pluripotent stem cells from a patient with severe congenital neutropenia improves defective granulopoiesis","volume":"99","author":"Morishima","year":"2014","journal-title":"Haematologica"},{"key":"10.1016\/j.exphem.2019.01.005_bib0032","doi-asserted-by":"crossref","first-page":"8869","DOI":"10.1074\/jbc.C200651200","article-title":"Nod2 is a general sensor of peptidoglycan through muramyl dipeptide (MDP) detection","volume":"278","author":"Girardin","year":"2003","journal-title":"J Biol Chem"},{"key":"10.1016\/j.exphem.2019.01.005_bib0033","doi-asserted-by":"crossref","first-page":"5509","DOI":"10.1074\/jbc.C200673200","article-title":"Host recognition of bacterial muramyl dipeptide mediated through NOD2. Implications for Crohn's disease","volume":"278","author":"Inohara","year":"2003","journal-title":"J Biol Chem"},{"key":"10.1016\/j.exphem.2019.01.005_bib0034","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/j.jaci.2017.04.013","article-title":"Pluripotent stem cell models of Blau syndrome reveal an IFN-gamma-dependent inflammatory response in macrophages","volume":"141","author":"Takada","year":"2018","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.exphem.2019.01.005_bib0035","doi-asserted-by":"crossref","first-page":"3625","DOI":"10.1002\/art.30512","article-title":"High incidence of NLRP3 somatic mosaicism in patients with chronic infantile neurologic, cutaneous, articular syndrome: results of an International Multicenter Collaborative Study","volume":"63","author":"Tanaka","year":"2011","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.exphem.2019.01.005_bib0036","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1007\/s11926-011-0165-y","article-title":"Current status of understanding the pathogenesis and management of patients with NOMID\/CINCA","volume":"13","author":"Goldbach-Mansky","year":"2011","journal-title":"Curr Rheumatol Rep"},{"key":"10.1016\/j.exphem.2019.01.005_bib0037","doi-asserted-by":"crossref","first-page":"262","DOI":"10.3389\/fphar.2015.00262","article-title":"NLRP3 inflammasome and its inhibitors: a review","volume":"6","author":"Shao","year":"2015","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.exphem.2019.01.005_bib0038","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1002\/art.39960","article-title":"Identification of a high-frequency somatic NLRC4 mutation as a cause of autoinflammation by pluripotent cell-based phenotype dissection","volume":"69","author":"Kawasaki","year":"2017","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.exphem.2019.01.005_bib0039","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1038\/ng.3089","article-title":"An activating NLRC4 inflammasome mutation causes autoinflammation with recurrent macrophage activation syndrome","volume":"46","author":"Canna","year":"2014","journal-title":"Nat Genet"},{"key":"10.1016\/j.exphem.2019.01.005_bib0040","doi-asserted-by":"crossref","first-page":"2385","DOI":"10.1084\/jem.20141091","article-title":"An inherited mutation in NLRC4 causes autoinflammation in human and mice","volume":"211","author":"Kitamura","year":"2014","journal-title":"J Exp Med"},{"key":"10.1016\/j.exphem.2019.01.005_bib0041","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1038\/ng.3066","article-title":"Mutation of NLRC4 causes a syndrome of enterocolitis and autoinflammation","volume":"46","author":"Romberg","year":"2014","journal-title":"Nat Genet"},{"key":"10.1016\/j.exphem.2019.01.005_bib0042","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1002\/art.39961","article-title":"Editorial: it just takes one: somatic mosaicism in autoinflammatory disease","volume":"69","author":"Hoffman","year":"2017","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.exphem.2019.01.005_bib0043","doi-asserted-by":"crossref","first-page":"14914","DOI":"10.1073\/pnas.1106015108","article-title":"Proteasome assembly defect due to a proteasome subunit beta type 8 (PSMB8) mutation causes the autoinflammatory disorder, Nakajo\u2013Nishimura syndrome","volume":"108","author":"Arima","year":"2011","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.exphem.2019.01.005_bib0044","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1038\/nrm2630","article-title":"Molecular mechanisms of proteasome assembly","volume":"10","author":"Murata","year":"2009","journal-title":"Nat Rev Mol Cell Biol"},{"key":"10.1016\/j.exphem.2019.01.005_bib0045","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1016\/j.ajhg.2010.10.031","article-title":"PSMB8 encoding the beta5i proteasome subunit is mutated in joint contractures, muscle atrophy, microcytic anemia, and panniculitis\u2013induced lipodystrophy syndrome","volume":"87","author":"Agarwal","year":"2010","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.exphem.2019.01.005_bib0046","doi-asserted-by":"crossref","first-page":"4150","DOI":"10.1172\/JCI58414","article-title":"A mutation in the immunoproteasome subunit PSMB8 causes autoinflammation and lipodystrophy in humans","volume":"121","author":"Kitamura","year":"2011","journal-title":"J Clin Invest"},{"key":"10.1016\/j.exphem.2019.01.005_bib0047","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1159\/000351323","article-title":"A new infant case of Nakajo\u2013Nishimura syndrome with a genetic mutation in the immunoproteasome subunit: an overlapping entity with JMP and CANDLE syndrome related to PSMB8 mutations","volume":"227","author":"Kunimoto","year":"2013","journal-title":"Dermatology"},{"key":"10.1016\/j.exphem.2019.01.005_bib0048","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.1016\/j.stemcr.2018.04.004","article-title":"Pluripotent stem cell model of Nakajo\u2013Nishimura syndrome untangles proinflammatory pathways mediated by oxidative stress","volume":"10","author":"Honda-Ozaki","year":"2018","journal-title":"Stem Cell Reports"},{"key":"10.1016\/j.exphem.2019.01.005_bib0049","doi-asserted-by":"crossref","first-page":"4196","DOI":"10.1172\/JCI81260","article-title":"Additive loss-of-function proteasome subunit mutations in CANDLE\/PRAAS patients promote type I IFN production","volume":"125","author":"Brehm","year":"2015","journal-title":"J Clin Invest"},{"key":"10.1016\/j.exphem.2019.01.005_bib0050","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1038\/mp.2016.95","article-title":"Altered proliferation and networks in neural cells derived from idiopathic autistic individuals","volume":"22","author":"Marchetto","year":"2017","journal-title":"Mol Psychiatry"},{"key":"10.1016\/j.exphem.2019.01.005_bib0051","doi-asserted-by":"crossref","first-page":"eaaf3962","DOI":"10.1126\/scitranslmed.aaf3962","article-title":"The Src\/c-Abl pathway is a potential therapeutic target in amyotrophic lateral sclerosis","volume":"9","author":"Imamura","year":"2017","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.exphem.2019.01.005_bib0052","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.it.2018.11.005","article-title":"Epigenetic deregulation in human primary immunodeficiencies","volume":"40","author":"Campos-Sanchez","year":"2019","journal-title":"Trends Immunol"},{"key":"10.1016\/j.exphem.2019.01.005_bib0053","doi-asserted-by":"crossref","first-page":"2641","DOI":"10.1111\/cas.13731","article-title":"Unveiling epigenetic regulation in cancer, aging, and rejuvenation with in vivo reprogramming technology","volume":"109","author":"Sogabe","year":"2018","journal-title":"Cancer Sci"},{"key":"10.1016\/j.exphem.2019.01.005_bib0054","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/j.smim.2016.03.013","article-title":"Early hematopoiesis and macrophage development","volume":"27","author":"McGrath","year":"2015","journal-title":"Semin Immunol"},{"key":"10.1016\/j.exphem.2019.01.005_bib0055","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.immuni.2017.06.017","article-title":"Induced-pluripotent-stem-cell-derived primitive macrophages provide a platform for modeling tissue-resident macrophage differentiation and function","volume":"47","author":"Takata","year":"2017","journal-title":"Immunity"},{"key":"10.1016\/j.exphem.2019.01.005_bib0056","doi-asserted-by":"crossref","first-page":"e59243","DOI":"10.1371\/journal.pone.0059243","article-title":"Robust and highly-efficient differentiation of functional monocytic cells from human pluripotent stem cells under serum- and feeder cell-free conditions","volume":"8","author":"Yanagimachi","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.exphem.2019.01.005_bib0057","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1016\/j.omtn.2018.07.017","article-title":"Generation of HIV-resistant macrophages from IPSCs by using transcriptional gene silencing and promoter-targeted RNA","volume":"12","author":"Higaki","year":"2018","journal-title":"Mol Ther Nucleic Acids"},{"key":"10.1016\/j.exphem.2019.01.005_bib0058","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1126\/science.3296190","article-title":"The human hematopoietic colony-stimulating factors","volume":"236","author":"Clark","year":"1987","journal-title":"Science"},{"key":"10.1016\/j.exphem.2019.01.005_bib0059","doi-asserted-by":"crossref","first-page":"1820","DOI":"10.1126\/science.3051378","article-title":"Human IL-3 and GM-CSF act synergistically in stimulating hematopoiesis in primates","volume":"241","author":"Donahue","year":"1988","journal-title":"Science"},{"key":"10.1016\/j.exphem.2019.01.005_bib0060","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/j.stemcr.2015.01.005","article-title":"Large-scale hematopoietic differentiation of human induced pluripotent stem cells provides granulocytes or macrophages for cell replacement therapies","volume":"4","author":"Lachmann","year":"2015","journal-title":"Stem Cell Reports"},{"key":"10.1016\/j.exphem.2019.01.005_bib0061","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/j.stem.2013.09.002","article-title":"Induction of multipotential hematopoietic progenitors from human pluripotent stem cells via respecification of lineage\u2013restricted precursors","volume":"13","author":"Doulatov","year":"2013","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.exphem.2019.01.005_bib0062","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1038\/nature22370","article-title":"Haematopoietic stem and progenitor cells from human pluripotent stem cells","volume":"545","author":"Sugimura","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.exphem.2019.01.005_bib0063","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/j.stem.2014.01.011","article-title":"Expandable megakaryocyte cell lines enable clinically applicable generation of platelets from human induced pluripotent stem cells","volume":"14","author":"Nakamura","year":"2014","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.exphem.2019.01.005_bib0064","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1016\/j.cell.2018.06.011","article-title":"Turbulence activates platelet biogenesis to enable clinical scale ex vivo production","volume":"174","author":"Ito","year":"2018","journal-title":"Cell"},{"key":"10.1016\/j.exphem.2019.01.005_bib0065","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1016\/j.stem.2018.05.008","article-title":"Organoid center strategies for accelerating clinical translation","volume":"22","author":"Takebe","year":"2018","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.exphem.2019.01.005_bib0066","doi-asserted-by":"crossref","first-page":"7841","DOI":"10.1158\/0008-5472.CAN-10-0970","article-title":"microRNA signature and expression of Dicer and Drosha can predict prognosis and delineate risk groups in neuroblastoma","volume":"70","author":"Lin","year":"2010","journal-title":"Cancer Res"},{"key":"10.1016\/j.exphem.2019.01.005_bib0067","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1136\/heartjnl-2013-305402","article-title":"MicroRNAs in cardiovascular disease: an introduction for clinicians","volume":"101","author":"Romaine","year":"2015","journal-title":"Heart"},{"key":"10.1016\/j.exphem.2019.01.005_bib0068","doi-asserted-by":"crossref","first-page":"jcs203018","DOI":"10.1242\/jcs.203018","article-title":"Hematopoietic stem cells from induced pluripotent stem cells: considering the role of microRNA as a cell differentiation regulator","volume":"131","author":"Ferreira","year":"2018","journal-title":"J Cell Sci"},{"key":"10.1016\/j.exphem.2019.01.005_bib0069","doi-asserted-by":"crossref","first-page":"58ra84","DOI":"10.1126\/scitranslmed.3001522","article-title":"Identification of hematopoietic stem cell\u2013specific miRNAs enables gene therapy of globoid cell leukodystrophy","volume":"2","author":"Gentner","year":"2010","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.exphem.2019.01.005_bib0070","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1002\/stem.2332","article-title":"Molecular analysis of neutrophil differentiation from human induced pluripotent stem cells delineates the kinetics of key regulators of hematopoiesis","volume":"34","author":"Sweeney","year":"2016","journal-title":"Stem Cells"},{"key":"10.1016\/j.exphem.2019.01.005_bib0071","doi-asserted-by":"crossref","first-page":"2923","DOI":"10.1002\/stem.1800","article-title":"Conversion of human fibroblasts into monocyte\u2013like progenitor cells","volume":"32","author":"Pulecio","year":"2014","journal-title":"Stem Cells"},{"key":"10.1016\/j.exphem.2019.01.005_bib0072","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1016\/j.stem.2015.04.005","article-title":"Efficient detection and purification of cell populations using synthetic microRNA switches","volume":"16","author":"Miki","year":"2015","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.exphem.2019.01.005_bib0073","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1056\/NEJMoa1608368","article-title":"Autologous induced stem-cell-derived retinal cells for macular degeneration","volume":"376","author":"Mandai","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1016\/j.exphem.2019.01.005_bib0074","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/j.jjcc.2018.05.002","article-title":"Building a new strategy for treating heart failure using induced pluripotent stem cells","volume":"72","author":"Miyagawa","year":"2018","journal-title":"J Cardiol"},{"key":"10.1016\/j.exphem.2019.01.005_bib0075","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1038\/nature23664","article-title":"Human iPS cell-derived dopaminergic neurons function in a primate Parkinson's disease model","volume":"548","author":"Kikuchi","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.exphem.2019.01.005_bib0076","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1007\/s00018-017-2676-9","article-title":"iPSC-derived neural precursor cells: potential for cell transplantation therapy in spinal cord injury","volume":"75","author":"Nagoshi","year":"2018","journal-title":"Cell Mol Life Sci"},{"key":"10.1016\/j.exphem.2019.01.005_bib0077","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.stem.2015.06.013","article-title":"From dish to bedside: lessons learned while translating findings from a stem cell model of disease to a clinical trial","volume":"17","author":"McNeish","year":"2015","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.exphem.2019.01.005_bib0078","doi-asserted-by":"crossref","first-page":"3339","DOI":"10.1172\/JCI93521","article-title":"Activin-A enhances mTOR signaling to promote aberrant chondrogenesis in fibrodysplasia ossificans progressiva","volume":"127","author":"Hino","year":"2017","journal-title":"J Clin Invest"},{"key":"10.1016\/j.exphem.2019.01.005_bib0079","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1016\/j.neurobiolaging.2014.09.007","article-title":"Human secreted tau increases amyloid\u2013beta production","volume":"36","author":"Bright","year":"2015","journal-title":"Neurobiol Aging"},{"key":"10.1016\/j.exphem.2019.01.005_bib0080","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1126\/science.1250127","article-title":"Motor neuron disease. SMN2 splicing modifiers improve motor function and longevity in mice with spinal muscular atrophy","volume":"345","author":"Naryshkin","year":"2014","journal-title":"Science"}],"container-title":["Experimental Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301472X1930058X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301472X1930058X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T08:34:02Z","timestamp":1759566842000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0301472X1930058X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,3]]},"references-count":80,"alternative-id":["S0301472X1930058X"],"URL":"https:\/\/doi.org\/10.1016\/j.exphem.2019.01.005","relation":{},"ISSN":["0301-472X"],"issn-type":[{"value":"0301-472X","type":"print"}],"subject":[],"published":{"date-parts":[[2019,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Application of induced pluripotent stem cells to primary immunodeficiency diseases","name":"articletitle","label":"Article Title"},{"value":"Experimental Hematology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.exphem.2019.01.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 ISEH -- Society for Hematology and Stem Cells. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}